Decreases in Serum 7-alpha-Hydroxy-4-Cholesten-3-One (C4) Correlate Well with Anti-Fibrotic Efficacy of EDP-305 in Nonalcoholic Steatohepatitis (NASH) and Biliary Fibrosis Animal Models